1. Home
  2. CERO vs CISS Comparison

CERO vs CISS Comparison

Compare CERO & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • CISS
  • Stock Information
  • Founded
  • CERO 2017
  • CISS 2022
  • Country
  • CERO United States
  • CISS Greece
  • Employees
  • CERO N/A
  • CISS N/A
  • Industry
  • CERO
  • CISS Marine Transportation
  • Sector
  • CERO
  • CISS Consumer Discretionary
  • Exchange
  • CERO Nasdaq
  • CISS Nasdaq
  • Market Cap
  • CERO 3.1M
  • CISS 3.0M
  • IPO Year
  • CERO N/A
  • CISS N/A
  • Fundamental
  • Price
  • CERO $0.73
  • CISS $0.50
  • Analyst Decision
  • CERO
  • CISS
  • Analyst Count
  • CERO 0
  • CISS 0
  • Target Price
  • CERO N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • CERO 1.0M
  • CISS 57.1K
  • Earning Date
  • CERO 05-16-2025
  • CISS 05-27-2025
  • Dividend Yield
  • CERO N/A
  • CISS N/A
  • EPS Growth
  • CERO N/A
  • CISS N/A
  • EPS
  • CERO N/A
  • CISS N/A
  • Revenue
  • CERO N/A
  • CISS $42,296,101.00
  • Revenue This Year
  • CERO N/A
  • CISS N/A
  • Revenue Next Year
  • CERO N/A
  • CISS N/A
  • P/E Ratio
  • CERO N/A
  • CISS N/A
  • Revenue Growth
  • CERO N/A
  • CISS 47.17
  • 52 Week Low
  • CERO $0.65
  • CISS $0.48
  • 52 Week High
  • CERO $223.00
  • CISS $13.75
  • Technical
  • Relative Strength Index (RSI)
  • CERO 26.02
  • CISS 16.23
  • Support Level
  • CERO $0.65
  • CISS $0.68
  • Resistance Level
  • CERO $0.80
  • CISS $0.74
  • Average True Range (ATR)
  • CERO 0.10
  • CISS 0.04
  • MACD
  • CERO 0.04
  • CISS 0.00
  • Stochastic Oscillator
  • CERO 20.79
  • CISS 9.13

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: